BASF's €4.1 Billion Profit Hides a Cash Problem

Ludwigshafen | July 15, 2026 — BASF reported the largest quarterly net income in its recent history on Tuesday and simultaneously burned cash. Both facts sit in the same two-page preliminary release, and only one of them made the headlines.

The German group posted expected net income of €4.1 billion for the second quarter of 2026, against €79 million in the same quarter of 2025 — a roughly fifty-fold increase that comfortably beat the €2.4 billion analysts had penciled in. In the same three months, free cash flow came in at minus €0.2 billion, down from plus €0.5 billion a year earlier.

For anyone buying chemicals rather than BASF shares, the second number is the more instructive one.

The €3.9 billion that isn't operating performance

Of that €4.1 billion, some €3.9 billion is a pre-tax disposal gain from the coatings transaction with Carlyle and the Qatar Investment Authority, which closed on June 30 — the final day of the quarter. The deal valued BASF's automotive OEM coatings, refinish coatings and surface treatment businesses at an enterprise value of €7.7 billion, with BASF retaining a 40% stake. The associated tax expense is a mid-triple-digit million-euro figure.

Strip the gain out and the underlying picture is respectable but unremarkable. It does not touch EBITDA at all: group EBITDA was €2.0 billion, exactly in line with consensus, after roughly €0.4 billion of special items tied to the ongoing cost-savings programs and a new ERP rollout.

The headline, in other words, is a balance-sheet event dressed as an earnings event.

The cash arithmetic BASF left out

Here is the number that isn't in the release. Free cash flow in the first quarter of 2026 was minus €1,375 million. Add the second quarter's minus €0.2 billion and BASF has burned roughly €1.6 billion of free cash flow in the first half of 2026.

Full-year free cash flow guidance was left untouched at €1.5 billion to €2.3 billion.

That means the second half has to deliver somewhere between €3.1 billion and €3.9 billion in free cash flow. For scale: BASF generated approximately €2.6 billion across the second half of 2025. The company is therefore implicitly targeting an 18% to 49% improvement in second-half cash generation — while telling investors that raw material prices are precisely what is tying up its working capital.

BASF has a defensible answer ready: its free cash flow is structurally negative in the first quarter and recovers through the year, driven by the seasonality of Agricultural Solutions. That is true, and it was true in 2025. It does not resolve the tension. The €5.8 billion of pre-tax cash proceeds from the coatings closing will strengthen the balance sheet, but divestment proceeds do not flow through free cash flow as BASF defines it — operating cash flow of €0.5 billion, minus €0.7 billion of capex. The cash cushion and the cash target are two different conversations.

Analysts sit at the top of the range at €2.3 billion. Someone is going to be wrong on July 29.

The segment nobody will report: Chemicals missed

The group beat. The core did not.

EBITDA before special items of €2.4 billion exceeded the €2.1 billion consensus and the €1.6 billion of the prior-year quarter — but the composition matters. Materials, Industrial Solutions and Agricultural Solutions all came in considerably above analyst estimates. Nutrition & Care beat slightly. Chemicals and Surface Technologies both came in significantly below their respective consensus figures.

Chemicals is the cracker-and-basic-intermediates business. It is the segment most directly exposed to feedstock, and it is the segment that disappointed in a quarter defined by feedstock. Surface Technologies was the only segment whose earnings did not improve year on year at all — a notable data point for a standalone business now shorn of its coatings assets and left with battery materials and catalysts.

The beat came from downstream and from crop protection. It did not come from chemistry.

Price, not demand

Sales rose 16% to €17.2 billion, against a €16.5 billion consensus. The composition of that growth is the tell: prices contributed 11 percentage points, volumes 7, with currency and portfolio effects each subtracting one.

This is not a demand recovery. It is cost pass-through in a disrupted market — and BASF's own revised assumptions confirm it. Buried in the outlook section, the company rebased its 2026 planning assumptions:

A 23% upward revision to the oil assumption, paired with a 60-basis-point cut to expected chemical production growth. BASF is raising its earnings outlook while lowering its forecast for the industry it operates in. That combination only makes sense one way: margin captured on rising feedstock, in a market where volume is not the constraint — supply is.

Buyers modelling second-half contract prices now have the world's largest chemical producer on record at $80 Brent. That is the single most actionable line in the document.

The raise is retrospective

BASF lifted its 2026 EBITDA before special items guidance to €6.9–7.7 billion, from €6.2–7.0 billion. Consensus already stood at €7.3 billion — the exact midpoint of the new range. The upgrade catches up to the street; it does not surprise it.

More telling is what the range implies. First-half EBITDA before special items was approximately €4.8 billion (€2.36 billion in Q1, €2.4 billion in Q2). Against the new full-year range, that leaves an implied second half of roughly €2.1–2.9 billion — versus approximately €2.5 billion in the second half of 2025. Midpoint: flat.

BASF has raised guidance by banking a strong first half and assuming no improvement whatsoever thereafter. Management said as much, if obliquely: the width of the range is unchanged because of continuing geopolitical uncertainty. This is not a company calling a recovery.

Everything rests on Hormuz

BASF is unusually explicit about why. The release states that second-half performance depends to a considerable degree on the outcome of US–Iran negotiations, specifically regarding access to and use of the Strait of Hormuz for transporting energy and petrochemical feedstocks from the Middle East. A prolonged closure would weigh significantly on economic activity; a rapid framework agreement would add momentum.

That is a DAX-listed chemical major making its earnings outlook contingent on a single maritime chokepoint, in a preliminary release, in bold. The strait — through which roughly a fifth of global oil and LNG moved before February 2026 — has been substantially disrupted since the conflict began, and talks have repeatedly stalled and restarted. BASF's $80 Brent assumption is a bet on that file resolving. Its unchanged cash flow guidance is the same bet, made twice.

What this means for buyers

Three takeaways for procurement teams:

1. Treat the $80 Brent assumption as a planning floor, not a forecast. It is a downside-protected number from a producer with every incentive to be conservative on cost and confident on margin.

2. Watch the Chemicals segment, not the group. A consensus miss in basic chemicals during a feedstock spike suggests margin compression at the front of the chain that downstream results are masking. If it persists into Q3, expect it to surface as intermediates pricing pressure.

3. The cash gap is the thing to test on July 29. If BASF cannot articulate where €3.1–3.9 billion of second-half free cash flow comes from, the working capital build is structural rather than seasonal — and structural working capital builds end in destocking.

BASF publishes its Half-Year Financial Report on July 29, with an analyst call at 8:30 a.m. CEST.

All figures are preliminary and drawn from BASF SE's news release P-26-132 of July 15, 2026, and its Q1 2026 quarterly statement of April 30, 2026. Half-year and second-half calculations are ChemAnalyst's own, derived from those disclosures.